Genomics Market Research Reports & Industry Analysis
Genomics is dedicated to the study, analysis, and application of genetic materials. As the field of genomics advances, its effects are felt across various industries including healthcare, biotechnology, and personalized medicine. MarketResearch.com offers comprehensive genomics industry reports to help you stay informed in this fast-growing industry.
Genomics Market Size and Analysis
- Our reports cover various genomics markets extensively, including genomics, proteomics, and cell biology technology.
- We provide in-depth insights into market dynamics, offering market size data, growth projections, and analysis of key technological innovations, industry trends, and competitor strategies.
- Additionally, our genomics research highlights emerging trends that could significantly impact the industry. Being aware of these trends is vital for long-term success in an ever-changing landscape.
Insights for Informed Decisions
Our genomics market research reports provide reliable data for making informed decisions, helping you increase revenue and capitalize on emerging opportunities. Our team of research specialists is on standby to assist you by providing tailored recommendations to fit your specific needs. As the genomics field evolves, count on MarketResearch.com for valuable insights to maintain your competitive edge.
Genomics Industry Research & Market Reports
-
Predictive Diagnostics
... CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$821.4 Million While China is Forecast to Grow at 9.9% CAGR The Predictive Diagnostics market in the U.S. is estimated at ... Read More
-
SNP Genotyping and Analysis
... 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. SNP Genotyping by Microarrays and GeneChips, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach ... Read More
-
Synthetic DNA
... CAGR of 18.7% over the analysis period 2024-2030. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of the ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
Genomics
... 19.1% over the analysis period 2024-2030. Genomics Consumables, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$123.2 Billion by the end of the analysis period. Growth ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Electrocompetent Cells, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Protein Extracts from Single Cell Protein and Other Conventional Sources
... Billion in the year 2024, is expected to reach US$44.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Plant Protein Extract, one of the segments analyzed in the report, ... Read More
-
Predictive Genetic Testing and Consumer Genomics
... reach US$20.7 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Predictive Testing, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach ... Read More
-
microRNA (miRNA)
... CAGR of 13.1% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$411.8 Million by the end of the analysis period. ... Read More
-
Gene Amplification Technologies
... at a CAGR of 10.0% over the analysis period 2024-2030. Medical & Pharma, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.4 Billion by the end ... Read More
-
Animal Genetics
... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Gene Delivery Systems
... at a CAGR of 6.5% over the analysis period 2024-2030. Viral Gene, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.1 Billion by the end of ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... the year 2024, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Biochips & Microarrays, one of the segments analyzed in the report, is expected ... Read More
-
2025 Global Gene Expression Analysis Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the end ... Read More
-
Optogenetics Actuators and Sensors
... 2030, growing at a CAGR of 1.9% over the analysis period 2024-2030. Actuators, one of the segments analyzed in the report, is expected to record a 1.5% CAGR and reach US$405.4 Million by the end ... Read More
-
Recombinant DNA Technology
... at a CAGR of 4.5% over the analysis period 2024-2030. Medical, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.9 Billion by the end of the ... Read More
-
Life Science Tools
... at a CAGR of 8.0% over the analysis period 2024-2030. Cell Biology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$84.6 Billion by the end of ... Read More
-
Genetic Testing
... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More
-
Ancestry and Relationship Testing
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Online, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$1.1 Billion by the end ... Read More
-
Artificial Intelligence (AI) in Genomics
... Billion by 2030, growing at a CAGR of 40.6% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 43.7% CAGR and reach US$4.6 Billion by ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More